NICE recommends Bristol-Myers Squibb’s Daklinza to treat chronic hepatitis C virus infection
Specifically, NICE recommended Daklinza, an oral, once-daily medication used in combination with other agents, to treat certain patients with HCV genotypes 1, 3 and 4. Approximately 214,000 people